How to Write a Continuous Intravenous Infusion Order for Penicillin G
For an 18 million unit daily dose of Penicillin G administered as a continuous infusion over 24 hours, write the order as: "Penicillin G 18 million units in 500 mL normal saline, infuse continuously at 20.8 mL/hour (750,000 units/hour) over 24 hours for 14 days." 1
Order Components
Dosing and Preparation
- Total daily dose: 18 million units per 24 hours 2
- Diluent: Reconstitute with Sterile Water for Injection or Sterile Isotonic Sodium Chloride Solution 1
- Final concentration: Dilute 18 million units in 500 mL normal saline to achieve 36,000 units/mL 1
- Infusion rate: Set at 20.8 mL/hour to deliver the total dose over 24 hours 1
Administration Details
The order should specify continuous intravenous infusion rather than intermittent dosing because continuous infusion maintains therapeutic concentrations above the minimum inhibitory concentration (MIC) throughout the dosing interval, which is critical for time-dependent beta-lactam antibiotics like penicillin 3, 4. The FDA label explicitly states that continuous intravenous drip is appropriate for high-dose penicillin therapy 1.
- Start with a loading dose of 3-4 million units IV bolus to rapidly achieve steady-state concentrations before initiating the continuous infusion 3
- Adjust infusion rate based on patient's fluid requirements (typically 2 liters per 24 hours for adults) 1
- Duration: Continue for 14 days for most serious infections 2
Monitoring Requirements
Essential monitoring parameters include:
- Renal function: Check creatinine clearance before initiating therapy 1
- Electrolytes: Monitor potassium levels, as each million units of Penicillin G potassium contains approximately 1.7 mEq of potassium 1
- Clinical response: Assess fever, symptoms, and signs of infection daily 1
- IV site: Inspect for phlebitis or infiltration every shift 1
Renal Dose Adjustments
For patients with renal impairment 1:
- Creatinine clearance <10 mL/min/1.73m²: Give full loading dose, then reduce maintenance to one-half the loading dose every 8-10 hours (consider switching from continuous to intermittent dosing)
- Creatinine clearance >10 mL/min/1.73m² (uremic patients): Give full loading dose, then one-half the loading dose every 4-5 hours
Alternative Therapy for Penicillin Allergy
If the patient has a documented penicillin allergy, vancomycin 30 mg/kg/day IV in 2 divided doses is the recommended alternative 5. However, this requires confirmation of true allergy 1:
- For patients with unclear allergy history, consider penicillin skin testing before defaulting to vancomycin 6
- Ceftriaxone 2 g IV daily is an alternative for some indications, but cross-reactivity with penicillin exists 2
- Vancomycin trough levels should be maintained at 10-15 mcg/mL 7, 8, 9
Stability and Storage
Critical stability considerations:
- Refrigerate reconstituted solutions; stable for 7 days when refrigerated 1
- Solutions in PVC bags or elastomeric pumps are stable for 21 days at 5°C 10
- Penicillins are rapidly inactivated in carbohydrate solutions at alkaline pH—avoid dextrose-containing solutions for long-term infusions 1
- Inspect solution for particulate matter before administration 1
Common Pitfalls to Avoid
- Do not use dextrose solutions for continuous infusion due to pH-related degradation 1
- Do not administer the 20 million unit vial by any route other than IV infusion—it is not suitable for intramuscular injection 1
- Do not assume oral absorption is reliable in critically ill patients; IV route is preferred 11
- Ensure adequate IV access, as continuous infusion requires dedicated line patency for 24 hours 12
Sample Complete Order
"Penicillin G potassium 18 million units in 500 mL 0.9% sodium chloride IV continuous infusion at 20.8 mL/hour (750,000 units/hour) for 14 days. Give 3 million units IV bolus over 30 minutes before starting continuous infusion. Monitor renal function, potassium, and clinical response daily. If penicillin allergy confirmed, substitute with vancomycin 15 mg/kg IV every 12 hours with trough monitoring." 2, 1